Obesity and diabetes share a common insulin resistance pathway and contribute to chronic hyperglycemia. Both high-intensity interval exercise (HIIE) and focused ultrasound (FUS) have been explored in the context of managing insulin resistance in diabetic individuals with abdominal obesity, though they operate through different mechanisms and have different implications.
Forty diabetic females aged 25 to 35 years old and body mass index was ≥ 30 kg/m², will participate in this study. They will be assigned into two equal groups, Group A will receive high intensity interval exercise 2 times per week for 4 months in addition to intermitted fasting diet. Group B will receive focused ultrasound 2 times per week for 4 months in addition to intermitted fasting diet. Assessment of abdominal obesity will be applied pre and post treatment through measuring Body mass index (BMI), Waist circumference (WC) in addition to Value of HbA1c and HOMA-IR hormone will be measured to determine effect of treatment on insulin resistance.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
HIIT is a type of interval training exercise. It incorporates several rounds that alternate between several minutes of high intensity movements followed by short periods of lower intensity movements 2 times per week for 4 months.
Focused ultrasound will be applied over the anterior abdominal, two sessions per week for 4 months, each session 40 minutes.
Body mass index
The weight and height of each woman in both groups will be measured to calculate the body mass index (BMI)
Time frame: Before starting the study and after 4 months of treatment
Waist circumference
Assessment of waist circumference of each woman by the tape measurement
Time frame: Before starting the study and after 4 months of treatment
Skin fold
The thickness of the abdominal fold will be measured using skinfold calipers to provide information on changes in subcutaneous fat in the abdominal region.
Time frame: Before starting the study and after 4 months of treatment
Value of HbA1c and HOMA-IR hormone
Value of HbA1c and HOMA-IR hormone will be measured to determine effect of treatment on insulin resistance.
Time frame: Before starting the study and after 4 months of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.